Skip to main content

Calian Reports Record Results for the Second Quarter of Fiscal 2026

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

(All amounts in release are in Canadian dollars)

OTTAWA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX:CGY), a mission critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, today released its results for the second quarter ended March 31, 2026.

"Our second quarter results mark an important inflection point for Calian as we begin to capture the benefits of strengthening demand across the defence sector," said Patrick Houston, Calian CEO. "Revenue grew 18%, including 12% organic growth, which was achieved through record-setting deliveries and a strong pace of contract signings. This solid top-line performance translated into an 60% increase in adjusted EBITDA1, which significantly outpaced revenue growth and reflects the compounded impact of higher volumes and improved operational leverage.

These results reflect early but tangible momentum in government defence spending and validate the strategic choices we have made to sharpen our operating model. With a $1.5 billion backlog, a robust acquisition pipeline, and a solid balance sheet, we are well-positioned to capture market share, deliver strong full year performance, and create lasting value for shareholders."

Q2-26 Highlights2:

  • Revenue up 18% to $229 million, including 12% from organic and 6% from acquisitions
  • Gross margin increased to 35.1%, up from 33.4%
  • Adjusted EBITDA1 up 60% to $28 million (margin of 12.2% versus 9.0% last year)
  • Operating free cash flow1 of $21 million, representing a conversion of 77%
  • New contract signings of $321 million, including over $200 million in defence
  • Ending backlog of $1.5 billion, including over one billion in defence
  • On February 10, 2026 Calian announced the appointment of Will Majic as Acting CFO
  • On March 26, 2026, Calian increased its committed credit facility to pursue growth
                 
Financial Highlights   Three months endedSix months ended
(in millions of $, except per share & margins)
March 31,March 31,
    2026  20252  %  2026  20252 %
Revenue
 228.7   193.7  18 % 436.7   378.7 15 %
Adjusted EBITDA1
 27.9   17.4  60 % 50.7   35.2 44 %
Adjusted EBITDA %1
 12.2 %  9.0 % 320bps 11.6 %  9.3 %230bps
Adjusted Net Profit1
 15.1   9.1  65 % 26.9   17.6 53 %
Adjusted EPS Diluted1
 1.30   0.77  69 % 2.33   1.47 58 %
Operating Free Cash Flow1
 21.5   9.8  119 % 37.2   22.9 63 %
                 

1 This is a non-GAAP measure. Please refer to the section “Reconciliation of non-GAAP measures to most comparable IFRS measures” at the end of this press release.
2 Highlights are compared to the three-month and six-month periods ended March 31, 2025.

Access the full report on the Calian Financials web page.
Register for the conference call on Thursday, May 14, 2026, 8:30 a.m. Eastern Time.

Second Quarter Results

Revenues increased 18%, from $194 million to $229 million. This represents a record high quarterly revenue for the Company. Acquisitive growth was 6% and was generated by the acquisitions of Advanced Medical Solutions completed in May 2025 and Infield Scientific closed in October 2025. Organic growth was 12% and was generated by both the Defence & Space and Essential Industries segments.

Gross profit increased 24.3% to $80 million, driven by revenue growth, changes in revenue mix and contributions from acquisitions. As a result, gross margin reached 35.1%, up from 33.4% last year. Similarly, adjusted EBITDA1 increased 60% to $28 million, driven by higher gross profit. As a result, adjusted EBITDA1 margin increased to 12.2%, up from 9.0% last year.

Net profit was $6.7 million, or $0.58 per diluted share, compared to $0.3 million, or $0.02 per diluted share last year. The increase is primarily related to higher adjusted EBITDA1 and lower mergers and acquisition costs, partially offset by higher restructuring expenses and taxes. Adjusted net profit1 stood at $15.1 million, or $1.30 per diluted share, up from $9.1 million, or $0.77 per diluted share, last year.

Liquidity and Capital Resources

"In the second quarter, we generated $21 million of operating free cash flow1, representing a strong conversion rate from adjusted EBITDA1 of 77%," said Will Majic, Calian Acting CFO. "We used our cash and a portion of our credit facility to fund capital expenditures of $4 million, earn-outs related to past acquisitions for $5 million and provide a return to shareholders through dividends of $3 million. We ended the quarter with a net debt to adjusted EBITDA1 ratio of 1.2x, preserving significant financial flexibility to fund our growth strategy."

Calian Appoints Will Majic as Acting Chief Financial Officer

On February 23, 2026, Calian announced the appointment of Will Majic as acting Chief Financial Officer, effective immediately. Majic joined Calian in 2017 and currently serves as Vice President, Finance. He previously held the roles of Director of Finance and Controller. During his tenure, Calian has grown from approximately $275 million in annual revenue to more than $750 million. He has led finance due diligence and integration for 19 acquisitions, supported two equity financings totalling $150 million, and played a key role in establishing a $350 million syndicated credit facility. He also led enterprise-wide ERP implementation and enhanced internal controls, reporting standards and cash flow management to support the company’s expanding operations.

Calian Increases its Committed Credit Facility to Pursue Growth

On March 26, 2026, Calian announced that it has exercised the accordion feature under its existing credit facility. Calian has exercised $75 million of its accordion feature, increasing total committed capacity under its credit facility to $275 million. The Company renewed its credit facility on September 29, 2025, for a three-year term, with total capacity of $350 million.

Quarterly Dividend

On May 13, 2026, Calian declared a quarterly dividend of $0.28 per share. The dividend is payable June 10, 2026, to shareholders of record as of May 27, 2026. Dividends paid by the Company are considered “eligible dividend” for tax purposes.

About Calian

www.calian.com

For over 40 years, Calian has delivered mission-critical solutions when failure is not an option. Trusted worldwide, we empower organizations in critical industries to overcome obstacles, manage risks and drive progress. By combining the expertise of our people, proven industry insight, cutting-edge technology, bold innovation, and global reach, we deliver tailored solutions that solve complex challenges. Headquartered in Ottawa, Canada, with over 6,000 people around the world, Calian’s solutions protect lives, strengthen security, foster global connectivity and drive economic progress, making a lasting impact where and when it matters most. 

Product or service names mentioned herein may be the trademarks of their respective owners.

Media inquiries:
media@calian.com
613-599-8600

Investor Relations inquiries:
ir@calian.com

-------------------------------------------------------------
DISCLAIMER

Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
Tel: 613.599.8600 · Fax: 613-592-3664 · General info email: info@calian.com

CALIAN GROUP LTD.
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
As at March 31, 2026 and September 30, 2025
(Canadian dollars in thousands, except per share data)
 
        
  March 31, September 30, 
  2026 2025 
ASSETS       
CURRENT ASSETS       
Cash and cash equivalents $56,348 $46,101 
Accounts receivable  298,169  171,150 
Work in process  18,381  25,028 
Inventory  27,851  27,709 
Prepaid expenses and other  34,841  22,977 
Derivative assets  182  44 
Total current assets  435,772  293,009 
NON-CURRENT ASSETS       
Property, plant and equipment  45,631  45,508 
Right of use assets  39,828  39,786 
Prepaid expenses  7,551  6,015 
Deferred tax asset  1,521  1,614 
Investments  4,252  4,252 
Acquired intangible assets  97,204  106,833 
Goodwill  231,407  224,483 
Total non-current assets  427,394  428,491 
TOTAL ASSETS $863,166 $721,500 
LIABILITIES AND SHAREHOLDERS’ EQUITY       
CURRENT LIABILITIES       
Accounts payable and accrued liabilities $224,057 $133,096 
Provisions  3,681  3,458 
Unearned contract revenue  49,830  39,646 
Lease obligations  6,120  5,819 
Contingent earn-out  5,168  16,147 
Derivative liabilities  153  53 
Total current liabilities  289,009  198,219 
NON-CURRENT LIABILITIES       
Debt facility  167,250  130,750 
Lease obligations  37,882  37,634 
Unearned contract revenue  19,730  14,704 
Deferred tax liabilities  16,807  18,912 
Total non-current liabilities  241,669  202,000 
TOTAL LIABILITIES  530,678  400,219 
        
SHAREHOLDERS’ EQUITY       
Issued capital  229,359  220,345 
Contributed surplus  6,292  7,312 
Retained earnings  89,763  84,360 
Accumulated other comprehensive income (loss)  7,074  9,264 
TOTAL SHAREHOLDERS’ EQUITY  332,488  321,281 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $863,166 $721,500 
Number of common shares issued and outstanding  11,490,510  11,350,168 


CALIAN GROUP LTD.
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF NET PROFIT
For the three months and six months ended March 31, 2026 and 2025
(Canadian dollars in thousands, except per share data)
 
 Three months ended Six months ended
 March 31, March 31,
 2026 2025  2026 2025 
Revenue $228,701  $193,667   $436,700  $378,714 
Cost of revenues  148,364   129,025    285,461   255,271 
Gross profit  80,337   64,642    151,239   123,443 
            
Selling, general and administrative  48,533   44,477    94,351   82,582 
Research and development  3,933   2,771    6,203   5,667 
Share-based compensation  1,821   949    2,833   2,040 
Profit before under noted items  26,050   16,445    47,852   33,154 
            
Restructuring and other  2,043   372    2,462   1,064 
Depreciation and amortization  11,136   11,474    22,141   23,014 
Mergers and acquisition costs  977   2,373    1,995   4,693 
Profit before interest and income tax expense  11,894   2,226    21,254   4,383 
            
Interest expense  2,212   2,111    4,428   3,894 
Income tax expense (recovery)  2,967   (180)   5,015   1,170 
NET PROFIT (LOSS) $6,715  $295   $11,811  $(681)
            
Net profit (loss) per share:           
Basic $0.59  $0.03   $1.03  $(0.06)
Diluted $0.58  $0.02   $1.03  $(0.06)


CALIAN GROUP LTD.
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the three months and six months ended March 31, 2026 and 2025
(Canadian dollars in thousands)
 
  Three months ended Six months ended
  March 31, March 31,
   2026   2025   2026   2025 
CASH FLOWS GENERATED FROM (USED IN) OPERATING ACTIVITIES            
Net profit (loss) $6,715  $295  $11,811  $(681)
Items not affecting cash:            
Interest expense  1,705   1,612   3,399   2,907 
Changes in fair value related to contingent earn-out     558   100   1,116 
Lease obligations interest expense  507   499   1,029   987 
Income tax expense  2,967   (180)  5,015   1,170 
Share based compensation expense  1,821   949   2,833   2,040 
Depreciation and amortization  11,136   11,474   22,141   23,014 
Deemed compensation  250   1,470   589   3,033 
   25,101   16,677   46,917   33,586 
Change in non-cash working capital            
Accounts receivable  (124,090)  (55,935)  (126,539)  (56,102)
Work in process  5,234   668   6,647   900 
Prepaid expenses and other  (3,659)  3,884   (13,875)  1,146 
Inventory  158   2,637   (142)  (3,605)
Accounts payable and accrued liabilities  91,185   48,068   90,853   47,210 
Unearned contract revenue  11,339   1,092   15,210   2,386 
   5,268   17,091   19,071   25,521 
Interest paid  (2,212)  (2,111)  (4,428)  (3,894)
Income tax paid  (2,134)  (5,120)  (6,554)  (7,385)
   922   9,860   8,089   14,242 
CASH FLOWS GENERATED FROM (USED IN) FINANCING ACTIVITIES            
Issuance of common shares net of costs  4,104   664   4,480   1,545 
Dividends  (3,213)  (3,292)  (6,408)  (6,584)
Net draw on debt facility  2,500   5,000   36,500   31,000 
Payment of lease obligations  (1,508)  (1,664)  (3,107)  (3,106)
Repurchase of common shares     (4,384)     (9,310)
   1,883   (3,676)  31,465   13,545 
CASH FLOWS USED IN INVESTING ACTIVITIES            
Business acquisitions  (5,259)  (678)  (23,443)  (11,893)
Property, plant and equipment  (3,834)  (2,396)  (5,864)  (3,532)
   (9,093)  (3,074)  (29,307)  (15,425)
             
NET CASH INFLOW $(6,288) $3,110  $10,247  $12,362 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD  62,636   61,040   46,101   51,788 
CASH AND CASH EQUIVALENTS, END OF PERIOD $56,348  $64,150  $56,348  $64,150 


Reconciliation of Non-GAAP Measures to Most Comparable IFRS Measures

These non-GAAP measures are mainly derived from the consolidated financial statements, but do not have a standardized meaning prescribed by IFRS; therefore, others using these terms may calculate them differently. The exclusion of certain items from non-GAAP performance measures does not imply that these are necessarily nonrecurring. From time to time, we may exclude additional items if we believe doing so would result in a more transparent and comparable disclosure. Other entities may define the above measures differently than we do. In those cases, it may be difficult to use similarly named non-GAAP measures of other entities to compare performance of those entities to the Company’s performance.

Management believes that providing certain non-GAAP performance measures, in addition to IFRS measures, provides users of the Company’s financial reports with enhanced understanding of the Company’s results and related trends and increases transparency and clarity into the core results of the business. Adjusted EBITDA excludes items that do not reflect, in our opinion, the Company’s core performance and helps users of our MD&A to better analyze our results, enabling comparability of our results from one period to another.

Adjusted EBITDA

   Three months ended  Six months ended
   March 31,  March 31,
   2026  2025   2026  2025 
Net profit (loss) $6,715 $295  $11,811 $(681)
Share-based compensation  1,821  949   2,833  2,040 
Restructuring and other  2,043  372   2,462  1,064 
Depreciation and amortization  11,136  11,474   22,141  23,014 
Mergers and acquisition costs  977  2,373   1,995  4,693 
Interest expense  2,212  2,111   4,428  3,894 
Income tax expense  2,967  (180)  5,015  1,170 
Adjusted EBITDA $27,871 $17,394  $50,685 $35,194 
Adjusted EBITDA per share - Basic  2.43  1.48   4.44  3.00 
Adjusted EBITDA per share - Diluted $2.40 $1.46  $4.40 $2.95 


Adjusted Net Profit and Adjusted EPS

   Three months ended  Six months ended
   March 31,  March 31,
   2026   2025   2026   2025 
Net profit (loss) $6,715  $295  $11,811  $(681)
Share-based compensation  1,821   949   2,833   2,040 
Restructuring and other  2,043   372   2,462   1,064 
Mergers and acquisition costs  977   2,373   1,995   4,693 
Amortization of intangibles  6,376   7,066   12,760   14,400 
   17,932   11,055   31,861   21,516 
Income taxes related to above items  (2,842)  (1,913)  (5,002)  (3,966)
Adjusted net profit  15,090   9,142   26,859   17,550 
Weighted average number of common shares basic  11,454,308   11,726,127   11,416,792   11,749,796 
Adjusted EPS Basic  1.32   0.78   2.35   1.49 
Adjusted EPS Diluted $1.30  $0.77  $2.33  $1.47 


Operating Free Cash Flow

   Three months ended  Six months ended
   March 31,  March 31,
   2026   2025   2026   2025 
Cash flows generated from operating activities (free cash flow) $922  $9,860  $8,089  $14,242 
Adjustments:            
M&A costs included in operating activities  727   345   1,306   544 
Change in non-cash working capital  19,833   (414)  27,846   8,065 
Operating free cash flow $21,482  $9,791  $37,241  $22,851 
Operating free cash flow per share - basic  1.88   0.83   3.26   1.94 
Operating free cash flow per share - diluted  1.85   0.82   3.23   1.92 
Operating free cash flow conversion  77 %  56 %  73 %  65 %


Net Debt to Adjusted EBITDA

  March 31, March 31, 
   2026  2025 
Cash $        56,348         $        64,150         
Debt facility          167,250                  120,750         
Net debt (net cash)          110,902                  56,600         
Trailing twelve month adjusted EBITDA          93,910                  78,846         
Net debt to adjusted EBITDA          1.2                  0.7         


Operating free cash flow measures the company’s cash profitability after required capital spending when excluding working capital changes. The Company’s ability to convert adjusted EBITDA to operating free cash flow is critical for the long term success of its strategic growth. These measurements better align the reporting of our results and improve comparability against our peers. We believe that securities analysts, investors and other interested parties frequently use non-GAAP measures in the evaluation of issuers. Management also uses non-GAAP measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements. Non-GAAP measures should not be considered a substitute for or be considered in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-GAAP measures and view them in conjunction with the most comparable IFRS financial measures. The Company has reconciled adjusted profit to the most comparable IFRS financial measure as shown above.


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.13
+0.00 (0.00%)
AAPL  298.87
+0.00 (0.00%)
AMD  445.50
+0.00 (0.00%)
BAC  49.84
+0.00 (0.00%)
GOOG  399.04
+0.00 (0.00%)
META  616.63
+0.00 (0.00%)
MSFT  405.21
+0.00 (0.00%)
NVDA  225.83
+0.00 (0.00%)
ORCL  189.76
+0.00 (0.00%)
TSLA  445.27
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.